Japan - Medicaments Containing Hormones But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingJapan: Medicaments Containing Hormones Market 2024
Medicaments Containing Hormones Market Size in Japan
The Japanese medicaments containing hormones market rose remarkably to $X in 2023, surging by X% against the previous year. Over the period under review, the total consumption indicated resilient growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption decreased by X% against 2021 indices. Medicaments containing hormones consumption peaked at $X in 2016; however, from 2017 to 2023, consumption failed to regain momentum.
Medicaments Containing Hormones Production in Japan
In value terms, medicaments containing hormones production rose sharply to $X in 2023 estimated in export price. Over the period under review, production saw a strong increase. The most prominent rate of growth was recorded in 2015 when the production volume increased by X% against the previous year. Medicaments containing hormones production peaked at $X in 2016; however, from 2017 to 2023, production failed to regain momentum.
Medicaments Containing Hormones Exports
Exports from Japan
In 2023, exports of medicaments containing hormones but not antibiotics from Japan contracted significantly to X tons, with a decrease of X% on 2022 figures. In general, exports faced a abrupt contraction. The pace of growth was the most pronounced in 2022 with an increase of X%. Over the period under review, the exports hit record highs at X tons in 2017; however, from 2018 to 2023, the exports failed to regain momentum.
In value terms, medicaments containing hormones exports shrank rapidly to $X in 2023. Overall, exports, however, posted notable growth. The pace of growth appeared the most rapid in 2014 when exports increased by X% against the previous year. Over the period under review, the exports reached the maximum at $X in 2022, and then dropped sharply in the following year.
Exports by Country
South Korea (X tons) was the main destination for medicaments containing hormones exports from Japan, with a X% share of total exports. Moreover, medicaments containing hormones exports to South Korea exceeded the volume sent to the second major destination, the UK (X kg), more than tenfold.
From 2012 to 2023, the average annual growth rate of volume to South Korea was relatively modest.
In value terms, the largest markets for medicaments containing hormones exported from Japan were South Korea ($X) and the UK ($X).
The UK, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, in terms of the main countries of destination over the period under review.
Export Prices by Country
In 2023, the average medicaments containing hormones export price amounted to $X per ton, reducing by X% against the previous year. In general, the export price, however, continues to indicate significant growth. The pace of growth was the most pronounced in 2019 when the average export price increased by X%. Over the period under review, the average export prices attained the maximum at $X per ton in 2021; however, from 2022 to 2023, the export prices stood at a somewhat lower figure.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to South Korea stood at $X per ton.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to the UK (X%), while the prices for the other major destinations experienced a decline.
Medicaments Containing Hormones Imports
Imports into Japan
In 2023, supplies from abroad of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the second consecutive year after three years of decline. Over the period under review, imports, however, showed a mild reduction. Imports peaked at X tons in 2012; however, from 2013 to 2023, imports failed to regain momentum.
In value terms, medicaments containing hormones imports soared to $X in 2023. In general, imports, however, continue to indicate a pronounced descent. Imports peaked at $X in 2012; however, from 2013 to 2023, imports stood at a somewhat lower figure.
Imports by Country
In 2023, Germany (X tons) was the main supplier of medicaments containing hormones to Japan, accounting for a approx. X% share of total imports.
From 2012 to 2023, the average annual rate of growth in terms of volume from Germany amounted to X%.
In value terms, Germany ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to Japan.
From 2012 to 2023, the average annual rate of growth in terms of value from Germany totaled X%.
Import Prices by Country
The average medicaments containing hormones import price stood at $X per ton in 2023, surging by X% against the previous year. In general, the import price, however, continues to indicate a pronounced descent. The pace of growth was the most pronounced in 2018 when the average import price increased by X%. The import price peaked at $X per ton in 2012; however, from 2013 to 2023, import prices failed to regain momentum.
As there is only one major supplying country, the average price level is determined by prices for Germany.
From 2012 to 2023, the rate of growth in terms of prices for Germany amounted to X% per year.
Source: IndexBox Platform
This report provides an in-depth analysis of the medicaments containing hormones market in Japan. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)
Country coverage:
- Japan
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Japan
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the medicaments containing hormones market in Asia.
This report provides an in-depth analysis of the medicaments containing hormones market in the U.S..
This report provides an in-depth analysis of the medicaments containing hormones market in China.
This report provides an in-depth analysis of the medicaments containing hormones market in the EU.
This report provides an in-depth analysis of the global medicaments containing hormones market.